- Increase of the net earnings of $777,027 as compared to the second
quarter of 2008 and $1,773,527 as compared to the six-month period
ended June 30, 2008
- Increase of the adjusted operating earnings of 245.0% as compared to
the second quarter of 2008 and 97.4% as compared to the six-month
period ended June 30, 2008
- Integration of the nutritional bar manufacturing activities in the
St-Eustache plant was carried out as planned
MONTREAL, Aug. 28 /CNW Telbec/ - Ranaz Corporation ("Ranaz") (TSX-V :
RNZ), a company specialized in the manufacturing and marketing of protein and
dietary supplements, reported its results today for the second quarter ended
June 30, 2009.
Sales for the second quarter of 2009 totalled $5.7 millions as compared
to $6.7 millions in the same quarter of 2008. Sales for the first six months
of 2009 totalled $10.0 millions, down of $1.1 million or 9.8% as compared to
the same period of 2008. The sales for Protidiet increased compare to the same
quarter of 2008 due to the higher demand for our products in United States.
"Given the current macroeconomic environment that characterized the first
half of 2009, we are proud that Protidiet sales continued to increase. This
growth has enabled us to absorb the slowdown in sales for Protilife and
Bartech. With the current backlog of orders, we can affirm that our customers
are loyal and this should enable us to catch our sales forecast. "Said Jean
Bourassa-Marineau, President and founder of Ranaz.
"During the second quarter, we completed the integration of the bar line.
We took this opportunity to invest in our infrastructure products to make
significant improvements. Our short term goal is to improve our daily
production capacity. With the bars now in St-Eustache, the entire production
team can now respond in real time. "Said Bernard Prévot, the Manufacturing
The Company has net earnings of $368,108 or $0.008 per share for the
second quarter of 2009, as compared to a net loss of $408,919 or $0.011 per
share last year, which represent an increase of 190%. This decrease of the net
loss was mainly attributable to the drop of selling expenses of 45.7% and the
administrative expenses drop of 21.4%.
Full results including the financial statements and management discussion
and analysis are available on SEDAR website at www.sedar.com.
About Ranaz Corporation
Ranaz is a corporation specializing in the manufacture and marketing of
protein and dietary supplements. Its mission is to design, develop and market
nutritional, protein and dietary supplements under its own corporate brands
and concepts, such as Protidiet and ProtiLife, as well as under private
labels. For more information about the Company, please visit our website at
Certain statements contained in this news release, other than statements
of fact that are independently verifiable at the date hereof, may constitute
forward-looking statements. Such statements, based as they are on the current
expectations of management, inherently involve numerous risks and
uncertainties, known and unknown, many of which are beyond Ranaz's control.
Such risks include but are not limited to: the impact of general economic
conditions, changes in the regulatory environment in the jurisdictions in
which Ranaz does business, stock markets volatility, fluctuations in costs,
and changes to the competitive environment due to consolidation, as well as
other risks disclosed in public filings of Ranaz. Consequently, actual future
results may differ materially from the anticipated results expressed in the
forward-looking statements. The reader should not place undue reliance, if
any, on the forward-looking statements included in this news release. These
statements speak only as of the date made and Ranaz is under no obligation and
disavows any intention to update or revise such statements as a result of any
event, circumstances or otherwise.
The TSX Venture Exchange has not reviewed and does not accept
responsibility for the adequacy or accuracy of this release.
For further information:
For further information: Ranaz Corporation: Sylvain Picard, CMA, Chief
Financial Officer, Director of Accounting & Administration, (450) 491-7106,
poste 264, email@example.com; Groupe Evolution: Jean-François
Bouffard, Investor's Relations, (514) 448-4887, (866) 703-4887,